21.38
price up icon0.52%   0.11
after-market 시간 외 거래: 21.45 0.07 +0.33%
loading
전일 마감가:
$21.27
열려 있는:
$21.27
하루 거래량:
831.24K
Relative Volume:
1.30
시가총액:
$960.66M
수익:
$681.75M
순이익/손실:
$70.47M
주가수익비율:
14.74
EPS:
1.45
순현금흐름:
$173.19M
1주 성능:
-1.66%
1개월 성능:
-17.04%
6개월 성능:
-20.52%
1년 성능:
+28.80%
1일 변동 폭
Value
$20.96
$21.77
1주일 범위
Value
$20.50
$21.85
52주 변동 폭
Value
$16.00
$27.98

Pacira Biosciences Inc Stock (PCRX) Company Profile

Name
명칭
Pacira Biosciences Inc
Name
전화
650-242-8052
Name
주소
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
Name
직원
790
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
PCRX's Discussions on Twitter

PCRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
PCRX
Pacira Biosciences Inc
21.38 955.72M 681.75M 70.47M 173.19M 1.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-25 업그레이드 Truist Hold → Buy
2025-01-30 업그레이드 Truist Sell → Hold
2024-08-13 다운그레이드 Truist Buy → Sell
2024-08-12 다운그레이드 JP Morgan Overweight → Underweight
2024-08-12 다운그레이드 Piper Sandler Overweight → Neutral
2024-08-12 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2024-08-12 다운그레이드 Raymond James Outperform → Mkt Perform
2024-07-03 다운그레이드 Barclays Overweight → Equal Weight
2024-03-07 재개 JP Morgan Overweight
2023-12-20 개시 Raymond James Outperform
2023-08-03 업그레이드 TD Cowen Market Perform → Outperform
2023-01-31 재개 Wedbush Outperform
2022-10-21 재개 Jefferies Buy
2022-01-03 재개 JP Morgan Overweight
2021-07-26 업그레이드 JP Morgan Neutral → Overweight
2021-04-21 재개 JP Morgan Neutral
2021-04-09 개시 Berenberg Buy
2021-04-07 재개 RBC Capital Mkts Outperform
2021-02-11 다운그레이드 Northland Capital Outperform → Market Perform
2021-01-21 다운그레이드 SVB Leerink Outperform → Mkt Perform
2020-09-21 업그레이드 Northland Capital Market Perform → Outperform
2020-07-06 재확인 Needham Buy
2020-05-27 개시 Guggenheim Neutral
2020-04-07 개시 Northland Capital Outperform
2020-03-20 업그레이드 SVB Leerink Mkt Perform → Outperform
2020-02-24 재확인 H.C. Wainwright Buy
2020-01-24 개시 SunTrust Buy
2020-01-23 개시 SunTrust Buy
2019-11-06 개시 BTIG Research Buy
2019-06-11 개시 Barclays Overweight
2019-05-06 업그레이드 Mizuho Underperform → Neutral
2019-05-02 업그레이드 Stifel Sell → Hold
2019-02-01 다운그레이드 Mizuho Neutral → Underperform
2018-08-06 다운그레이드 BofA/Merrill Buy → Neutral
2018-04-09 재확인 H.C. Wainwright Buy
2018-03-21 재확인 Mizuho Neutral
2018-02-16 다운그레이드 Needham Buy → Hold
2018-01-19 개시 Seaport Global Securities Buy
2018-01-04 재확인 Canaccord Genuity Buy
2018-01-03 개시 Leerink Partners Mkt Perform
모두보기

Pacira Biosciences Inc 주식(PCRX)의 최신 뉴스

pulisher
06:30 AM

Why Pacira BioSciences Inc. (82P) stock could outperform next yearJuly 2025 Volume & Community Consensus Picks - newser.com

06:30 AM
pulisher
06:14 AM

Pacira BioSciences Inc. recovery potential after sell off2025 Market Overview & Community Consensus Stock Picks - newser.com

06:14 AM
pulisher
05:24 AM

How to integrate Pacira BioSciences Inc. into portfolio analysis toolsTrade Risk Report & AI Based Buy and Sell Signals - newser.com

05:24 AM
pulisher
05:13 AM

Building trade automation scripts for Pacira BioSciences Inc.2025 Momentum Check & Fast Moving Stock Watchlists - newser.com

05:13 AM
pulisher
04:34 AM

Can a trend reversal in Pacira BioSciences Inc. lead to recoveryJuly 2025 Rallies & Stepwise Trade Signal Implementation - newser.com

04:34 AM
pulisher
02:12 AM

Real time social sentiment graph for Pacira BioSciences Inc.2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - newser.com

02:12 AM
pulisher
01:31 AM

Is Pacira BioSciences Inc. stock poised for growthBuy Signal & Free Accurate Trade Setup Notifications - newser.com

01:31 AM
pulisher
01:07 AM

Chart based analysis of Pacira BioSciences Inc. trendsJuly 2025 Update & Fast Exit Strategy with Risk Control - newser.com

01:07 AM
pulisher
12:40 PM

Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025 - markets.businessinsider.com

12:40 PM
pulisher
Oct 30, 2025

Pacira BioSciences Inc. stock retracement – recovery analysis2025 Growth vs Value & High Accuracy Buy Signal Tips - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Pacira Biosciences, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Trends - Markets Mojo

Oct 30, 2025
pulisher
Oct 30, 2025

Pacira BioSciences (PCRX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Pacira BioSciences (Nasdaq: PCRX) sets Nov. 6 third-quarter results; call at 4:30 p.m. ET - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

Will Pacira BioSciences Inc. stock keep outperforming rivalsMarket Sentiment Report & Technical Analysis for Trade Confirmation - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

What is the fair value estimate for Pacira BioSciences Inc. (82P) stock in 2025Market Trend Review & Weekly Momentum Stock Picks - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee - markets.businessinsider.com

Oct 29, 2025
pulisher
Oct 28, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Oct 28, 2025
pulisher
Oct 28, 2025

Pacira BioSciences, Inc. Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-To-Severe Osteoarthritis of the Knee - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Pacira BioSciences (PCRX) Reports Promising Three-Year Findings for PCRX-201 - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Is Pacira BioSciences Inc. stock a buy on dipsForecast Cut & Smart Investment Allocation Insights - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Pacira Biosciences Increceives Paragraph IV notice from Qilu Pharmaceutical - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

Pacira BioSciences receives patent challenge for EXPAREL from Chinese firm - Investing.com

Oct 27, 2025
pulisher
Oct 27, 2025

Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL® - The Manila Times

Oct 27, 2025
pulisher
Oct 27, 2025

Pacira BioSciences Receives PIV Notice from Qilu Pharmaceutical Regarding Generic EXPAREL Patent Claims - Quiver Quantitative

Oct 27, 2025
pulisher
Oct 27, 2025

Pacira BioSciences (NASDAQ: PCRX) notes PIV ANDA for EXPAREL; 45 days to file suit - Stock Titan

Oct 27, 2025
pulisher
Oct 27, 2025

How Pacira BioSciences Inc. stock trades before earnings2025 Risk Factors & Low Drawdown Momentum Ideas - newser.com

Oct 27, 2025

Pacira Biosciences Inc (PCRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
자본화:     |  볼륨(24시간):